Published in J Clin Oncol on March 29, 2004
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage (2007) 1.83
Central nervous system cancers. J Natl Compr Canc Netw (2013) 1.82
The future of high-grade glioma: Where we are and where are we going. Surg Neurol Int (2015) 1.50
Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neurooncol (2011) 1.46
Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma. Neurology (2011) 1.38
Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol (2007) 1.24
Senior adult oncology. J Natl Compr Canc Netw (2012) 1.20
Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol (2011) 1.17
MRI perfusion in determining pseudoprogression in patients with glioblastoma. Clin Imaging (2012) 1.13
Value of 11C-methionine PET in imaging brain tumours and metastases. Eur J Nucl Med Mol Imaging (2012) 1.12
Role of radiation therapy in palliative care of the patient with cancer. J Clin Oncol (2014) 1.12
Health-related quality of life in patients with high-grade glioma. Neuro Oncol (2008) 1.10
Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006. Neuro Oncol (2012) 1.08
Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. AJNR Am J Neuroradiol (2015) 1.04
Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. J Neurooncol (2012) 0.98
Treatment options and outcomes for glioblastoma in the elderly patient. Clin Interv Aging (2014) 0.98
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma. Clin Cancer Res (2014) 0.98
Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial. Front Oncol (2012) 0.97
Advances in the molecular genetics of gliomas - implications for classification and therapy. Nat Rev Clin Oncol (2016) 0.96
Standards of care and novel approaches in the management of glioblastoma multiforme. Chin J Cancer (2014) 0.95
What next for newly diagnosed glioblastoma? Future Oncol (2015) 0.94
Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas. Core Evid (2010) 0.94
The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme. Neuro Oncol (2009) 0.93
Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future? Br J Radiol (2012) 0.91
NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age. Expert Rev Neurother (2014) 0.91
Assessment and treatment relevance in elderly glioblastoma patients. Neuro Oncol (2014) 0.90
Anti-cancer Therapies in High Grade Gliomas. Curr Proteomics (2013) 0.86
Radiation and concomitant chemotherapy for patients with glioblastoma multiforme. Chin J Cancer (2013) 0.86
Management of elderly patients with gliomas. Oncologist (2014) 0.86
Hospitalization burden and survival among older glioblastoma patients. Neuro Oncol (2014) 0.84
A review of management strategies of malignant gliomas in the elderly population. Am J Cancer Res (2014) 0.84
Towards personalized therapy for patients with glioblastoma. Expert Rev Anticancer Ther (2011) 0.83
Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme. Strahlenther Onkol (2011) 0.82
A Surveillance, Epidemiology and End Results-Medicare data analysis of elderly patients with glioblastoma multiforme: Treatment patterns, outcomes and cost. Mol Clin Oncol (2015) 0.82
What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma? J Clin Oncol (2005) 0.81
The radiosensitivity index predicts for overall survival in glioblastoma. Oncotarget (2015) 0.81
Radiation treatment in older patients: a framework for clinical decision making. J Clin Oncol (2014) 0.80
Neuro-oncology: treatment decisions in elderly patients with glioblastoma. Nat Rev Neurol (2012) 0.80
Elderly patients with glioblastoma multiforme treated with concurrent temozolomide and standard- versus abbreviated-course radiotherapy. Perm J (2015) 0.80
Neuro-oncology: The many challenges of treating elderly glioblastoma patients. Nat Rev Neurol (2015) 0.80
Toxicity and outcome of radiotherapy with concomitant and adjuvant temozolomide in elderly patients with glioblastoma: a retrospective study. Neurol Med Chir (Tokyo) (2013) 0.79
High-grade glioma in elderly patients: can the oncogeriatrician help? Clin Interv Aging (2013) 0.79
Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy. Cancers (Basel) (2013) 0.79
Hypofractionated chemoradiotherapy with temozolomide as a treatment option for glioblastoma patients with poor prognostic features. Int J Clin Oncol (2014) 0.78
Neuro-oncology: Five new things. Neurol Clin Pract (2013) 0.78
Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre. Strahlenther Onkol (2013) 0.78
Malignant gliomas: old and new systemic treatment approaches. Radiol Oncol (2016) 0.78
Nothing ventured, nothing gained: Treatment of glioblastoma multiforme in the elderly. J Clin Oncol (2004) 0.78
Proton beam irradiation stimulates migration and invasion of human U87 malignant glioma cells. J Radiat Res (2013) 0.77
Factors associated with increased survival after surgical resection of glioblastoma in octogenarians. PLoS One (2015) 0.76
Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution. Radiat Oncol (2015) 0.76
Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts. CNS Drugs (2017) 0.76
Highlights from the Literature. Neuro Oncol (2016) 0.75
Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma. J Neurooncol (2016) 0.75
Glioblastoma management: challenges in the elderly population. J Community Hosp Intern Med Perspect (2016) 0.75
Insights into molecular therapy of glioma: current challenges and next generation blueprint. Acta Pharmacol Sin (2017) 0.75
EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients. BMC Neurol (2015) 0.75
Comparative effectiveness of radiotherapy with vs. without temozolomide in older patients with glioblastoma. J Neurooncol (2016) 0.75
Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience. Radiat Oncol (2017) 0.75
Milestones of the last 10 years: CNS cancer. Memo (2017) 0.75
Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations. Cancer Manag Res (2009) 0.75
The radiosurgery fractionation quandary: single fraction or hypofractionation? Neuro Oncol (2017) 0.75
High-grade glioma management and response assessment-recent advances and current challenges. Curr Oncol (2016) 0.75
Regarding "abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial". J Clin Oncol (2005) 0.75
Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma. Contemp Oncol (Pozn) (2016) 0.75
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov. Radiat Oncol (2017) 0.75
Radiation de-intensification for patients with glioblastoma and poor prognostic features-how much do we really know? Neuro Oncol (2016) 0.75
The evolving roles and controversies of radiotherapy in the treatment of glioblastoma. J Med Radiat Sci (2016) 0.75
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study. Oncotarget (2017) 0.75
Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival. J Neurooncol (2017) 0.75
Management of GBM: a problem of local recurrence. J Neurooncol (2017) 0.75
Management and treatment recommendations for World Health Organization Grade III and IV gliomas. Int J Health Sci (Qassim) (2017) 0.75
Treatment and outcomes for glioblastoma in elderly compared with non-elderly patients: a population-based study. Curr Oncol (2017) 0.75
[Malignant gliomas--radiotherapy]. Wien Med Wochenschr (2006) 0.75
Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme. Cureus (2017) 0.75
Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults. Adolesc Health Med Ther (2017) 0.75
The role of radiation in treating glioblastoma: here to stay. J Neurooncol (2017) 0.75
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone. J Neurooncol (2017) 0.75
Feasibility evaluation of hypofractionated radiotherapy with concurrent temozolomide in elderly patients with glioblastoma. Int J Clin Oncol (2016) 0.75
New Hypofractionation Radiation Strategies for Glioblastoma. Curr Oncol Rep (2017) 0.75
Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol (1990) 18.71
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med (1985) 8.45
Duplication of CaMV 35S Promoter Sequences Creates a Strong Enhancer for Plant Genes. Science (1987) 6.00
Hepatitis C virus replication in mice with chimeric human livers. Nat Med (2001) 5.87
Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr (2001) 5.74
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med (2000) 5.72
1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N Engl J Med (1975) 5.48
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1995) 5.27
In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins. Appl Microbiol (1971) 5.23
Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem (1999) 4.77
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer (1999) 4.70
Giving patients their own records in general practice: experience of patients and staff. Br Med J (Clin Res Ed) (1986) 4.55
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50
Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun (1995) 4.33
The Innervation of the Human Gum. J Anat (1938) 4.26
Qualitative research and general practice. Br J Gen Pract (1993) 4.23
Global mapping of ecosystem services and conservation priorities. Proc Natl Acad Sci U S A (2008) 4.17
The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer (1975) 4.12
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol (1993) 4.09
Azlocillin: in vitro studies of a new semisynthetic penicillin. Antimicrob Agents Chemother (1977) 4.00
Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med (2010) 3.99
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer (1983) 3.94
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci (2001) 3.71
Degenerative changes in the axis cylinders of the dental nerves, due to diets deficient in vitamin A and carotene. J Physiol (1938) 3.65
The TIGR Gene Indices: clustering and assembling EST and known genes and integration with eukaryotic genomes. Nucleic Acids Res (2005) 3.53
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet (1994) 3.51
Analysis of cDNA clones specific for human T cells and the alpha and beta chains of the T-cell receptor heterodimer from a human T-cell line. Proc Natl Acad Sci U S A (1985) 3.41
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med (1985) 3.41
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol (2001) 3.40
Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med (1997) 3.31
Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem (2000) 3.30
Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med (1982) 3.27
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst (2000) 3.27
Universals and cultural differences in the judgments of facial expressions of emotion. J Pers Soc Psychol (1987) 3.22
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol (1990) 3.12
Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res (2000) 3.12
The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet (1981) 3.11
Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry (2000) 2.91
Cancer of the breast: size of neoplasm and prognosis. Cancer (1969) 2.91
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90
Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. J Clin Oncol (1990) 2.89
erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. J Natl Cancer Inst (1998) 2.85
Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage (2001) 2.84
Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys (1998) 2.77
A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat Cell Biol (2000) 2.72
Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol (1997) 2.71
The Intra-Mandibular Course of the Inferior Dental Nerve. J Anat (1931) 2.68
Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J Biol Chem (2001) 2.65
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort. Neurology (2012) 2.60
The Innervation of the Dentine. J Anat (1936) 2.59
A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene (1993) 2.59
Radiation and high-dose metronidazole in supratentorial glioblastomas. N Engl J Med (1976) 2.56
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol (1992) 2.53
Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage (1995) 2.51
The Innervation of the Periodontal Membrane of the Cat, with some Observations on the Function of the End-Organs found in that Structure. J Anat (1937) 2.49
A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer (1996) 2.49
A review and meta-analysis of the patient factors associated with psychiatric in-patient aggression. Acta Psychiatr Scand (2013) 2.48
A Comparative Study of the Innervation of the Gum: (Section of Odontology). Proc R Soc Med (1939) 2.46
Dual role for Escherichia coli RecA protein in SOS mutagenesis. Proc Natl Acad Sci U S A (1985) 2.43
The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction (1998) 2.41
Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res (2000) 2.39
Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes. Biol Blood Marrow Transplant (2002) 2.37
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep (1987) 2.37
Making a place in the metropolis: locational attainment in cities and suburbs. Demography (1996) 2.35
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2000) 2.32
The vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model. Clin Toxicol (Phila) (2014) 2.31
Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation. Ann Surg (1968) 2.29
Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res (2001) 2.28
Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial. Ann Surg (1970) 2.28
Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment. J Virol (2000) 2.24
Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol (1999) 2.23
Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods (2001) 2.22
Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res (1980) 2.21
Promoting parental leave for female and male physicians. Gender Issues Committee of the Council of Ontario Faculties of Medicine. CMAJ (2000) 2.20
Fraud in breast-cancer trials. N Engl J Med (1994) 2.18
Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease. JAMA (1997) 2.17
Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet (1970) 2.17
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer (1977) 2.16
EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism. Clin Exp Metastasis (1996) 2.16
Community development, user involvement, and primary health care. BMJ (1999) 2.15
Relationship between Arp2/3 complex and the barbed ends of actin filaments at the leading edge of carcinoma cells after epidermal growth factor stimulation. J Cell Biol (1999) 2.14
Current sickle cell screening program for newborns in New York City, 1979-1980. Am J Public Health (1983) 2.12
Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer (1978) 2.10
Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J Biol Chem (2000) 2.10
Cholecystoduodenoplasty for high-output duodenal fistula. Indian J Gastroenterol (2001) 2.09
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases. Cancer (1978) 2.08
The Innervation of the Periodontal Membrane. J Anat (1936) 2.07
Odour-absorbing dressings. J Wound Care (1998) 2.06
Striking a balance between biodiversity conservation and socioeconomic viability in the design of marine protected areas. Conserv Biol (2008) 1.99
Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med (2000) 1.98
Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation. Oral Oncol (2012) 1.98
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1994) 1.96
Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J Biol Chem (2000) 1.95